Residual Thromboembolic Risk and Outcomes of Oral Anticoagulation Discontinuation After Atrial Fibrillation Ablation: A Target Trial Emulation
{{output}}
Background and aims: Optimal management of oral anticoagulation (OAC) after atrial fibrillation (AF) ablation remains uncertain. We evaluated thromboembolic and bleeding outcomes associated with OAC discontinuation versus continu... ...
